M.D.C. Holdings Toekomstige groei

Future criteriumcontroles 1/6

M.D.C. Holdings zal naar verwachting groeien in winst en omzet met respectievelijk 8% en 6.6% per jaar. De winst per aandeel zal naar verwachting groeien met 7.2% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 13% zijn.

Belangrijke informatie

8.0%

Groei van de winst

7.2%

Groei van de winst per aandeel

Consumer Durables winstgroei	9.0%
Inkomstengroei	6.6%
Toekomstig rendement op eigen vermogen	13.0%
Dekking van analisten	Low
Laatst bijgewerkt	19 Apr 2024

Recente toekomstige groei-updates

Recent updates

M.D.C. Holdings, Inc.'s (NYSE:MDC) Intrinsic Value Is Potentially 24% Below Its Share Price

Sep 22

M.D.C. Holdings: Awaiting Q3 Results To Validate If Earnings Normalization Phase Has Started

Sep 06

We Think M.D.C. Holdings (NYSE:MDC) Can Stay On Top Of Its Debt

Sep 05

Upgrade: Analysts Just Made A Substantial Increase To Their M.D.C. Holdings, Inc. (NYSE:MDC) Forecasts

Aug 01

Is Now An Opportune Moment To Examine M.D.C. Holdings, Inc. (NYSE:MDC)?

Jul 28

We Like These Underlying Return On Capital Trends At M.D.C. Holdings (NYSE:MDC)

Jul 13

M.D.C. Holdings: Not The Best Financially But Has A Margin Of Safety

Jul 09

Does M.D.C. Holdings (NYSE:MDC) Have A Healthy Balance Sheet?

Jun 05

M.D.C. Holdings: Trends Are Turning, But Better To Wait And See

May 26

M.D.C. Holdings' (NYSE:MDC) Dividend Will Be $0.50

Apr 21

When Should You Buy M.D.C. Holdings, Inc. (NYSE:MDC)?

Apr 14

Returns on Capital Paint A Bright Future For M.D.C. Holdings (NYSE:MDC)

Mar 30

Does M.D.C. Holdings (NYSE:MDC) Have A Healthy Balance Sheet?

Mar 07

M.D.C. Holdings: Near-Term Concerns May Weigh On Share Price Performance

Feb 08

M.D.C. Q4 2022 Earnings Preview

Jan 30

M.D.C. Holdings (NYSE:MDC) Will Pay A Dividend Of $0.50

Jan 28

M.D.C. Holdings declares $0.50 dividend

Jan 24

M.D.C. Holdings, Inc. (NYSE:MDC) Shares Could Be 24% Above Their Intrinsic Value Estimate

Jan 13

Is M.D.C. Holdings, Inc. (NYSE:MDC) Potentially Undervalued?

Dec 29

Returns On Capital Are A Standout For M.D.C. Holdings (NYSE:MDC)

Dec 13

Winst- en omzetgroeiprognoses

NYSE:MDC - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
12/31/2026	5,672	502	269	294	1
12/31/2025	5,304	476	222	247	1
12/31/2024	4,885	423	289	314	3
12/31/2023	4,643	399	518	562	N/A
9/30/2023	4,816	359	1,162	1,185	N/A
6/30/2023	5,147	396	1,361	1,387	N/A
3/31/2023	5,498	492	1,186	1,214	N/A
12/31/2022	5,718	559	877	906	N/A
9/30/2022	5,664	642	194	222	N/A
6/30/2022	5,523	643	-79	-49	N/A
3/31/2022	5,437	608	-63	-32	N/A
12/31/2021	5,255	571	-238	-208	N/A
9/30/2021	5,014	555	-168	-139	N/A
6/30/2021	4,750	509	-94	-67	N/A
3/31/2021	4,269	439	-70	-44	N/A
12/31/2020	3,901	365	-50	-23	N/A
9/30/2020	3,781	311	95	120	N/A
6/30/2020	3,516	263	34	58	N/A
3/31/2020	3,348	233	-59	-34	N/A
12/31/2019	3,293	237	33	58	N/A
9/30/2019	3,071	199	-9	18	N/A
6/30/2019	3,084	202	76	104	N/A
3/31/2019	3,103	211	81	108	N/A
12/31/2018	3,065	210	-35	-8	N/A
9/30/2018	2,907	180	-83	-63	N/A
6/30/2018	2,726	187	-122	-108	N/A
3/31/2018	2,623	158	-93	-85	N/A
12/31/2017	2,578	141	68	71	N/A
9/30/2017	2,587	157	N/A	199	N/A
6/30/2017	2,580	122	N/A	260	N/A
3/31/2017	2,501	115	N/A	225	N/A
12/31/2016	2,327	103	N/A	116	N/A
9/30/2016	2,176	85	N/A	18	N/A
6/30/2016	2,048	74	N/A	-66	N/A
3/31/2016	1,932	67	N/A	-30	N/A
12/31/2015	1,909	66	N/A	0	N/A
9/30/2015	1,836	58	N/A	-17	N/A
6/30/2015	1,786	58	N/A	-23	N/A
3/31/2015	1,755	60	N/A	-34	N/A
12/31/2014	1,698	63	N/A	-164	N/A
9/30/2014	1,661	77	N/A	-217	N/A
6/30/2014	1,691	97	N/A	-220	N/A
3/31/2014	1,664	299	N/A	-328	N/A
12/31/2013	1,680	309	N/A	-270	N/A
9/30/2013	1,614	310	N/A	-284	N/A
6/30/2013	1,500	294	N/A	-239	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei MDC ( 8% per jaar) ligt boven de spaarquote ( 2.3% ).

Winst versus markt: De winst van MDC ( 8% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 15.4% per jaar).

Hoge groeiwinsten: De winst van MDC zal naar verwachting groeien, maar niet aanzienlijk.

Omzet versus markt: De omzet van MDC ( 6.6% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 9% per jaar).

Hoge groei-inkomsten: De omzet van MDC ( 6.6% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen MDC zal naar verwachting over 3 jaar laag zijn ( 13 %).

M.D.C. Holdings Toekomstige groei

Future criteriumcontroles 1/6

Belangrijke informatie

Recente toekomstige groei-updates

Price target increased by 9.3% to US$55.00

Consensus revenue estimates increase by 13%

Price target increased by 18% to US$48.88

M.D.C. Holdings, Inc. Provides Operating Guidance for the Third Quarter and Full Year of 2023

Price target increased by 18% to US$41.38

Consensus EPS estimates increase by 37%

Recent updates

Larry A. Mizel to Depart as Founder and Executive Chairman and David D. Mandarich to Depart as President of M.D.C. Holdings, Inc. on December 31, 2024

M.D.C. Holdings, Inc. Files Form 15

M.D.C. Holdings, Inc. Files Form 15

SH Residential Holdings, LLC completed the acquisition of M.D.C. Holdings, Inc. (NYSE:MDC) from a group of shareholders.

SH Residential Holdings, LLC completed the acquisition of M.D.C. Holdings, Inc. (NYSE:MDC) from a group of shareholders.

Independent Director recently sold US$389k worth of stock

Kaskela Law LLC Announces Shareholder Complaint Filed Against M.D.C. Holdings, Inc. (MDC) and Encourages Investors to Contact the Firm

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Upcoming dividend of US$0.55 per share at 3.5% yield

Third quarter dividend of US$0.55 announced

SH Residential Holdings, LLC entered into a definitive agreement to acquire M.D.C. Holdings, Inc. (NYSE:MDC) from a group of shareholders for $4.9 billion.

Investor sentiment improves as stock rises 16%

Price target increased by 9.3% to US$55.00

Sekisui House, Ltd. (TSE:1928) entered into a definitive agreement to acquire M.D.C. Holdings, Inc. (NYSE:MDC) from BlackRock, Inc. (NYSE:BLK), The Vanguard Group, Inc., Dimensional Fund Advisors LP, Larry Mizel, David Mandarich and others for $4.7 billion.

M.D.C. Sells To Sekisui At An Attractive Price; Further Upside Is Unlikely

Sekisui House, Ltd. (TSE:1928) entered into a definitive agreement to acquire M.D.C. Holdings, Inc. (NYSE:MDC) from BlackRock, Inc. (NYSE:BLK), The Vanguard Group, Inc., Dimensional Fund Advisors LP, Larry Mizel, David Mandarich and others for $4.7 billion.

Earnings Working Against M.D.C. Holdings, Inc.'s (NYSE:MDC) Share Price

We Think M.D.C. Holdings (NYSE:MDC) Can Stay On Top Of Its Debt

Returns On Capital At M.D.C. Holdings (NYSE:MDC) Have Hit The Brakes

M.D.C. Holdings: Navigating Through A Tough Housing Market

Investor sentiment improves as stock rises 17%

Is Now An Opportune Moment To Examine M.D.C. Holdings, Inc. (NYSE:MDC)?

Upcoming dividend of US$0.55 per share at 5.9% yield

Third quarter 2023 earnings released: EPS: US$1.45 (vs US$2.03 in 3Q 2022)

M.D.C. Holdings, Inc. Declares Quarterly Cash Dividend, Payable on November 22, 2023

M.D.C. Holdings, Inc. to Report Q3, 2023 Results on Oct 26, 2023

M.D.C. Holdings, Inc.'s (NYSE:MDC) Intrinsic Value Is Potentially 24% Below Its Share Price

M.D.C. Holdings: Awaiting Q3 Results To Validate If Earnings Normalization Phase Has Started

We Think M.D.C. Holdings (NYSE:MDC) Can Stay On Top Of Its Debt

Consensus revenue estimates increase by 13%

Upgrade: Analysts Just Made A Substantial Increase To Their M.D.C. Holdings, Inc. (NYSE:MDC) Forecasts

Upcoming dividend of US$0.55 per share at 4.3% yield

Price target increased by 18% to US$48.88

Senior VP & CFO exercised options and sold US$566k worth of stock

Independent Director recently sold US$284k worth of stock

M.D.C. Holdings, Inc. Provides Operating Guidance for the Third Quarter and Full Year of 2023

Is Now An Opportune Moment To Examine M.D.C. Holdings, Inc. (NYSE:MDC)?

New minor risk - Earnings quality

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Price target increased by 18% to US$41.38

We Like These Underlying Return On Capital Trends At M.D.C. Holdings (NYSE:MDC)

M.D.C. Holdings: Not The Best Financially But Has A Margin Of Safety

M.D.C. Holdings, Inc. to Report Q2, 2023 Results on Jul 27, 2023

M.D.C. Holdings, Inc.(NYSE:MDC) dropped from Russell Small Cap Comp Growth Index

Executive Chairman exercised options and sold US$30m worth of stock

Independent Director recently sold US$428k worth of stock

Does M.D.C. Holdings (NYSE:MDC) Have A Healthy Balance Sheet?

M.D.C. Holdings: Trends Are Turning, But Better To Wait And See

Independent Director notifies of intention to sell stock

Consensus EPS estimates increase by 37%

President recently sold US$6.5m worth of stock

Price target increased by 7.1% to US$35.17

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Upcoming dividend of US$0.50 per share at 4.9% yield

M.D.C. Holdings' (NYSE:MDC) Dividend Will Be $0.50

When Should You Buy M.D.C. Holdings, Inc. (NYSE:MDC)?

Returns on Capital Paint A Bright Future For M.D.C. Holdings (NYSE:MDC)

Independent Lead Director recently sold US$302k worth of stock

Independent Lead Director notifies of intention to sell stock

Does M.D.C. Holdings (NYSE:MDC) Have A Healthy Balance Sheet?

Independent Director recently sold US$170k worth of stock

Independent Director recently sold US$115k worth of stock

M.D.C. Holdings: Near-Term Concerns May Weigh On Share Price Performance

Consensus EPS estimates fall by 18%, revenue upgraded

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Upcoming dividend of US$0.50 per share at 5.4% yield

M.D.C. Q4 2022 Earnings Preview

M.D.C. Holdings (NYSE:MDC) Will Pay A Dividend Of $0.50

M.D.C. Holdings, Inc. Announces Executive Changes